Reply to “Interleukin-6 in acute heart failure: a marker of phenotype-specific biology or multimorbidity?”
Authors:
- 10 August 2026
- journal article
- letter
- Published by Springer Nature in Heart and Vessels
- p. 1-2
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Differential prognostic impact of interleukin-6 in acute heart failure with reduced versus preserved ejection fractionHeart and Vessels, 2026
- Heart Failure with Mid-Range Ejection Fraction in CHARM: Characteristics, Outcomes and Effect of Candesartan Across the Entire Ejection Fraction SpectrumEuropean Journal of Heart Failure, 2018
- A Novel Paradigm for Heart Failure With Preserved Ejection FractionJACC, 2013